Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Submitted on April 7, 2008
Accepted on July 2, 2008
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
John T. Dimos 1,Kit T. Rodolfa 2,Kathy K. Niakan 1,Laurin M. Weisenthal 1,Hiroshi Mitsumoto 3,Wendy Chung 4,Gist F. Croft 5,Genevieve Saphier 1,Rudy Leibel 6,Robin Goland 7,Hynek Wichterle 5,Christopher E. Henderson 5,Kevin Eggan 1*
1 Harvard Stem Cell Institute, Stowers Medical Institute, Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA. 2 Harvard Stem Cell Institute, Stowers Medical Institute, Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA. 3 Eleanor and Lou Gehrig MDA-ALS Research Center, Neurological Institute, Columbia University Medical Center, New York, NY 10032, USA.; Center for Motor Neuron Biology and Disease, Columbia University Medical Center, New York, NY 10032, USA. 4 Center for Motor Neuron Biology and Disease, Columbia University Medical Center, New York, NY 10032, USA.; Division of Molecular Genetics and Naomi Barrie Diabetes Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. 5 Center for Motor Neuron Biology and Disease, Columbia University Medical Center, New York, NY 10032, USA.; Departments of Pathology, Neurology and Neuroscience, Columbia University Medical Center, New York, NY 10032, USA. 6 Division of Molecular Genetics and Naomi Barrie Diabetes Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. 7 Department of Medicine and Naomi Barrie Diabetes Center, Columbia University Medical Center, New York, NY 10032, USA.
* To whom correspondence should be addressed.
Kevin Eggan , E-mail: eggan{at}mcb.harvard.edu
These authors contributed equally to this work.
The generation of pluripotent stem cells from an individualpatient would enable the large-scale production of the cell-typesaffected by that patients disease. These cells could inturn be used for disease modeling, drug discovery, and eventuallyautologous cell-replacement therapies. Although recent studieshave demonstrated the reprogramming of human fibroblasts toa pluripotent state, it remains unclear whether these inducedpluripotent stem (iPS) cells can be produced directly from elderlypatients with chronic disease. We have generated iPS cells froman 82-year-old woman diagnosed with a familial form of amyotrophiclateral sclerosis (ALS). These patient-specific iPS cells possessproperties of embryonic stem cells and were successfully directedto differentiate into motor neurons, the cell type destroyedin ALS.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Robert H. Brown Jr. (29 August 2008) Science321 (5893), 1169.
[DOI: 10.1126/science.1163475] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.
Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells.
L. Zwi, O. Caspi, G. Arbel, I. Huber, A. Gepstein, I.-H. Park, and L. Gepstein (2009)
Circulation
120, 1513-1523
|Abstract »|Full Text »|PDF »
A simple and efficient cryopreservation method for feeder-free dissociated human induced pluripotent stem cells and human embryonic stem cells.
S. Mollamohammadi, A. Taei, M. Pakzad, M. Totonchi, A. Seifinejad, N. Masoudi, and H. Baharvand (2009)
Hum. Reprod.
24, 2468-2476
|Abstract »|Full Text »|PDF »
Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells.
J. Utikal, N. Maherali, W. Kulalert, and K. Hochedlinger (2009)
J. Cell Sci.
122, 3502-3510
|Abstract »|Full Text »|PDF »
iPS Programmed Without c-MYC Yield Proficient Cardiogenesis for Functional Heart Chimerism.
A. Martinez-Fernandez, T. J. Nelson, S. Yamada, S. Reyes, A. E. Alekseev, C. Perez-Terzic, Y. Ikeda, and A. Terzic (2009)
Circ. Res.
105, 648-656
|Abstract »|Full Text »|PDF »
Generation of pluripotent stem cells from patients with type 1 diabetes.
R. Maehr, S. Chen, M. Snitow, T. Ludwig, L. Yagasaki, R. Goland, R. L. Leibel, and D. A. Melton (2009)
PNAS
106, 15768-15773
|Abstract »|Full Text »|PDF »
In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction.
F. Osakada, Z.-B. Jin, Y. Hirami, H. Ikeda, T. Danjyo, K. Watanabe, Y. Sasai, and M. Takahashi (2009)
J. Cell Sci.
122, 3169-3179
|Abstract »|Full Text »|PDF »
Repair of Acute Myocardial Infarction by Human Stemness Factors Induced Pluripotent Stem Cells.
T. J. Nelson, A. Martinez-Fernandez, S. Yamada, C. Perez-Terzic, Y. Ikeda, and A. Terzic (2009)
Circulation
120, 408-416
|Abstract »|Full Text »|PDF »
Progress and future challenges in stem cell-derived liver technologies.
D. M. Dalgetty, C. N. Medine, J. P. Iredale, and D. C. Hay (2009)
Am J Physiol Gastrointest Liver Physiol
297, G241-G248
|Abstract »|Full Text »|PDF »
Derivation of induced pluripotent stem cells from pig somatic cells.
T. Ezashi, B. P. V. L. Telugu, A. P. Alexenko, S. Sachdev, S. Sinha, and R. M. Roberts (2009)
PNAS
106, 10993-10998
|Abstract »|Full Text »|PDF »
Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases.
L. Ye, J. C. Chang, C. Lin, X. Sun, J. Yu, and Y. W. Kan (2009)
PNAS
106, 9826-9830
|Abstract »|Full Text »|PDF »
Cellular reprogramming and pluripotency induction.
Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS.
S. Karumbayaram, T. K. Kelly, A. A. Paucar, A. J. T. Roe, J. A. Umbach, A. Charles, S. A. Goldman, H. I. Kornblum, and M. Wiedau-Pazos (2009)
Dis. Model. Mech.
2, 189-195
|Abstract »|Full Text »|PDF »
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells.
J. Zhang, G. F. Wilson, A. G. Soerens, C. H. Koonce, J. Yu, S. P. Palecek, J. A. Thomson, and T. J. Kamp (2009)
Circ. Res.
104, e30-e41
|Abstract »|Full Text »|PDF »
Epigenetic reprogramming and induced pluripotency.